$146 Million is the total value of Stanley Capital Management, LLC's 35 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RLGY | Buy | REALOGY HLDGS CORP | $5,919,000 | +85.7% | 230,044 | +86.6% | 4.06% | +61.1% |
| MDCA | New | MDC PARTNERS INCcl a sub vtg | $4,110,000 | – | 627,439 | +100.0% | 2.82% | – |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $2,255,000 | -12.8% | 155,300 | +47.5% | 1.55% | -24.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROBERT HALF INTL INC | 36 | Q3 2023 | 4.8% |
| MOODYS CORP | 36 | Q3 2023 | 5.0% |
| BK OF AMERICA CORP | 36 | Q3 2023 | 5.5% |
| AMERICAN EXPRESS CO | 36 | Q3 2023 | 4.2% |
| MICROSOFT CORP | 36 | Q3 2023 | 4.1% |
| REALOGY HOLDINGS CORP | 36 | Q3 2023 | 5.0% |
| GOLDMAN SACHS GROUP INC | 36 | Q3 2023 | 3.2% |
| ALPHABET INC-CL A | 32 | Q3 2023 | 3.4% |
| ALPHABET INC-CL C | 31 | Q3 2023 | 2.5% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 6.8% |
View Stanley Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Stanley Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.